Diabetes: How Continuous Monitoring Reduces Heart Attack Risk by 72%

At the forefront is continuous ketone monitoring for at-risk patients. The goal is to detect severe metabolic imbalances, such as diabetic ketoacidosis (DKA), early and to avoid hospital admissions.

Significant Drop in Screening Age

Additionally, leading organizations like AHA, ACC, ADA, and ASN have introduced new CKM (Cardiovascular-Kidney-Metabolic) guidelines. The screening threshold for adults has been lowered to 30 to 75 years, irrespective of any existing cardiovascular conditions, marking a clear shift toward prevention.

The ADA also recommends general screening tests for adults without risk factors starting at age 35. For those with a BMI over 25, hypertension, or relevant family history, testing should begin even earlier. Experts advise regular checks starting at age 10 for overweight children and adolescents with at least one additional risk factor. Diagnostic methods include HbA1c, fasting plasma glucose, and the oral glucose tolerance test (OGTT).

CGM Drastically Lowers Risks

A South Korean study involving over 17,000 data sets collected from 2016 to 2022 has highlighted the benefits of continuous glucose monitoring (CGM). Users of CGM systems faced a 60% lower risk of diabetic ketoacidosis. The risk of kidney failure decreased by 57%, and the risk of coronary heart diseases was reduced by an impressive 72%. Overall mortality in the CGM group was also reported to be 62% lower.

Innovations in Insulin Pumps

The new ADA guidelines make the screening threshold 35 years, with CGM showing the potential to reduce heart attack risk by 72%. Learn how to incorporate CGM into your daily routine in our free guide: Request your free guide now.

The STRIVE study presented at the 2026 ADA conference demonstrated advancements in automated insulin dosing systems. Among Type 2 diabetes patients, time in range improved to 76%, while instances of hyperglycemia and average glucose levels decreased.

Continuing Care Gaps

Despite technological advancements, around 30% of adolescents receive insufficient care during the transition from pediatric to adult medicine. Medical professionals call for specialized networks and early preparations for this critical transition.

Over-the-Counter CGM for Young Children

In mid-June 2026, the FDA approved the first over-the-counter CGM system for children aged two years and older—as long as they do not require insulin. However, experts caution against potential risks, noting that close monitoring can lead to psychological stress or eating disorders.

Understand the importance of early recognition of ketoacidosis: CGM reduces the risk by 60%. Our report helps you avoid dangerous metabolic disturbances using CGM. Secure your Ketoacidosis Report now.

Sweeteners Under Scrutiny

A meta-analysis from Tufts University involving 21 randomized controlled trials indicates that non-nutritive sweeteners like aspartame or sucralose may negatively affect fasting insulin and HbA1c—possibly through changes in the gut microbiome. Therefore, effective diabetes management requires more than just monitoring blood values.